Innovation
Cambrex is a leader in the development and commercialization of small molecule therapeutics.
Experience
Cambrex has been providing solutions to small and large pharmaceutical companies for over 30 years.
Performance
Cambrex has an unwavering commitment to premium quality products and services.
Featured Story
Cambrex to Present at Jefferies 2012 Global Healthcare Conference
Cambrex Corporation's Steve Klosk, President and Chief Executive Officer, will make a presentation at the Jefferies 2012 Global Healthcare Conference on June 4, 2012 at 9:30 AM EDT in New York City.
Read more
Latest News RSS
Apr. 27, 2012
Cambrex Manufacturing Facility Completes Successful US FDA Inspection
Feb. 6, 2012
Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference
Jan. 27, 2012
Cambrex Launches Commercial Sufentanil and Sufentanil Citrate
Upcoming Events RSS
May. 22, 2012
ICSE USA
Jun. 4, 2012
Jefferies 2012 Global Healthcare Conference
Jun. 13, 2012
Chemspec Europe
Jun. 14, 2012
Biotech Outsourcing Strategies cmc
Investors RSS
May. 3, 2012
Cambrex Reports First Quarter 2012 Results
Apr. 27, 2012
Cambrex to Announce First Quarter 2012 Financial Results on May 3, 2012
Feb. 6, 2012
Cambrex Reports Fourth Quarter and Full Year 2011 Results
Contact Cambrex